SlideShare a Scribd company logo
bcn checkpoint 
V I H - S I D A ▪ I T S ▪ S E X U A L I T A T ▪ H O M E S ▪ S A L U T 
Results and Next Steps 
Michael Meulbroek 
Projecte dels NOMS-Hispanosida 
Challenges and opportunities for community testing centres 
Barcelona, 5 October de 2014
BCN Checkpoint opened in 2006
Results 
2007 2008 2009 2010 2011 2012 2013 
1. Number of tests 1.065 1.228 2.485 3.425 3.837 5.051 5.062 
2. Persons tested 903 1.124 2.201 2.896 3.198 4.049 4.030 
3. HIV positive 37 72 113 126 132 138 138 
4. % HIV positive 4,1% 6,4% 5,1% 4,4% 4,1% 3,4% 3,4% 
5. Persons at first visit BCN Checkpoint 850 957 1.583 1.722 1.689 1.717 1.682 
6. HIV positive at first visit 36 53 91 100 90 92 78 
7. % HIV positive at first visit 4,2% 5,5% 5,7% 5,8% 5,3% 5,4% 4,6%
Impact of BCN Checkpoint 
2007 2008 2009 2010 2011 2012 
2013 * 
(Prov.) 
1. Number of tests 1.098 1.272 2.483 3.453 3.962 5.051 5.062 
2. Persons tested 951 1.162 2.197 2.896 3.198 4.049 4.030 
3. HIV positive 37 72 113 126 132 138 138 
8. Total HIV cases in MSM reported in 
Catalonia 
319 300 280 360 374 430 357 
9. % of cases detected in 
BCN Checkpoint 
11,6% 24,0% 40,4% 35,0% 35,3% 32,1% 38,7% 
* Data Ceeiscat 3rd October 2014
Early detection 
• 31% of the new HIV cases detected in BCN Checkpoint are recent 
infections (< 6 months) 
• 57% of the new cases are infections < 12 months
Linkage to HIV unit (2009-2013) 
665 persons 
HIV reactive tests 
633 persons 
HIV reactive tests 
562 persons 
linked to care 
14 previously HIV positive 
71 persons 
non-linked 
24 persons returned 
to country of origin 
18 false positive 
33 persons 
Excluded: 
self-linked to care 
88,8% 
14 persons 
lost 
2,2% 3,8% 5,2%
Next Steps 
Community Research
Results Check-ear (2009-2014) 
Prevalence higher than in 
the general population 
• 250 participants 
• 16% prevalence asymptomatic STIs at 
baseline (1/6) 
• Gonorrhea (rectum 5,6% / penis 2,0%) 
• Chlamydia (rectum 6,3% / penis 3,1%)
Results Check-ear (2009-2014) 
Alternative effector-function profiling 
identifies broad HIV-specific T-cell 
responses in highly HIV-exposed 
individuals who remain uninfected. 
Ruiz-Riol M, Llano A, Ibarrondo J, Zamarreño J, Yusim 
K, Bach V, Mothe B, Perez-Alvarez S, Fernandez MA, 
Requena G, Meulbroek M, Pujol F, Leon A, Cobarsi P, 
Korber BT, Clotet B, Ganoza C, Sanchez J, Coll J, 
Brander C. 
Journal Infectious Diseases 2014 Sep 23. pii: jiu534
Next Steps 
Implementation of new services: 
 Syphilis, Chlamydia, Gonorrhea and HCV testing 
 Hepatitis A and B vaccination
The ÍTACA Cohort 
(December 2008 – December 2013) 
8.165 participants - 4.481 persons with follow-up visit 
223 infections HIV 
Incidence HIV: 2,43 x 100 persons/year 
(95% CI: 2,13 – 2,77) 
General population: incidence = 0,02%
Match prediction with reality? 
Prevalence and Awareness of HIV Infection Among Men Who Have Sex With Men — 
21 Cities, United States, 2008 (MMWR, Sept. 24, 2010, 59(37) 1201-7) 
Ronald Stall, PhD. Best Practices in HIV 
Prevention: Translating Innovation into 
Action. Boston, September 27, 2013
Next Steps 
So, we know what means an high HIV incidence… 
What are the behavior surveys we need? 
“HIV is increasing among MSM not because of greater risk-taking 
behavior, but simply because HIV is so prevalent among their sex partners 
that even one or two slip-ups can have devastating consequences.” 
Susan Buchbinder 
FDA Advisory Committee for PrEP approval 
10th May 2012
The effectiveness of condoms is limited / has peaked 
Uso del preservativo 
Siempre 714 56,3% 
Casi siempre 476 37,5% 
A veces 34 2,7% 
Casi nunca 15 1,2% 
Nunca 17 1,3% 
No contesta 13 1,0% 
Total 1,269 
Estudio Ítaca - BCN Checkpoint (2008-2011) 
93,8%
What can reduce HIV incidence? 
A. Phillips. MSM in the UK: Prevention Effects of ART in Perspective. 21st CROI, Boston, abstract 116, 2014
The problem: acute infections 
Source: Galvin/Cohen, 2004
Next Steps: more regular testing
Next Steps: use HIV RNA assay
Next Steps: Pre-Exposure Prophylaxis
Acknowledgements

More Related Content

PPTX
HIV self-testing among transgender women in San Francisco - a pilot
Cheryl Johnson
 
PPTX
Evaluation of rapid HIV self-testing among men who have sex with men in high ...
Cheryl Johnson
 
PDF
7 katz potential harms of hiv self-testing
SlidesShare_Foxtrot
 
PDF
CDC HIVST Mtg Seattle WA RM MO
SlidesShare_Foxtrot
 
PPTX
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
PDF
Zimbabwe HIV Self-testing presentation
SlidesShare_Foxtrot
 
PDF
CE_Selftesting_BMGF_Feb2015.pdf
SlidesShare_Foxtrot
 
PDF
Scaling up HIV testing: the role of self-testing
European Centre for Disease Prevention and Control
 
HIV self-testing among transgender women in San Francisco - a pilot
Cheryl Johnson
 
Evaluation of rapid HIV self-testing among men who have sex with men in high ...
Cheryl Johnson
 
7 katz potential harms of hiv self-testing
SlidesShare_Foxtrot
 
CDC HIVST Mtg Seattle WA RM MO
SlidesShare_Foxtrot
 
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
Zimbabwe HIV Self-testing presentation
SlidesShare_Foxtrot
 
CE_Selftesting_BMGF_Feb2015.pdf
SlidesShare_Foxtrot
 
Scaling up HIV testing: the role of self-testing
European Centre for Disease Prevention and Control
 

What's hot (20)

PPTX
HIV self-testing and linkage in Africa
Cheryl Johnson
 
PPTX
Michael Ison - USA -Tuesday 29 - Donor Risk
incucai_isodp
 
PDF
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
PDF
Facilitating HIV testing and linkage to care - the UK experience
European Centre for Disease Prevention and Control
 
PDF
The Kenya HIV Testing Services Guidelines 2015
Cheryl Johnson
 
PDF
10 Years of ACTS
Susan Wolfson
 
PPT
05 gilbert marksummit 2011
CBRC
 
PPTX
Rapid HIV Testing: Policy & Regulatory Issues
Australian Federation of AIDS Organisations
 
PDF
Scaling up HIV treatment - the Malta experience
European Centre for Disease Prevention and Control
 
PDF
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
PDF
Self-testing for HIV: initial experience of the UK’s first kit
Carmen Figueroa
 
PPTX
Where are we on HIV testing services - the achievements and the gaps
Cheryl Johnson
 
PPTX
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
DOCX
PARASITIC INFECTIONS ...
Society for Microbiology and Infection care
 
PPTX
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
Cheryl Johnson
 
PPTX
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
LIDC
 
PPTX
Testing technologies and STI testing
ReShape
 
PPTX
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
PPT
Extending advanced testing services to diagnose early HIV infection in gay me...
CBRC
 
PDF
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
HIV self-testing and linkage in Africa
Cheryl Johnson
 
Michael Ison - USA -Tuesday 29 - Donor Risk
incucai_isodp
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
Facilitating HIV testing and linkage to care - the UK experience
European Centre for Disease Prevention and Control
 
The Kenya HIV Testing Services Guidelines 2015
Cheryl Johnson
 
10 Years of ACTS
Susan Wolfson
 
05 gilbert marksummit 2011
CBRC
 
Rapid HIV Testing: Policy & Regulatory Issues
Australian Federation of AIDS Organisations
 
Scaling up HIV treatment - the Malta experience
European Centre for Disease Prevention and Control
 
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
Self-testing for HIV: initial experience of the UK’s first kit
Carmen Figueroa
 
Where are we on HIV testing services - the achievements and the gaps
Cheryl Johnson
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
HIV self-testing increases HIV testing frequency among high risk MSM: a rando...
Cheryl Johnson
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
LIDC
 
Testing technologies and STI testing
ReShape
 
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
Extending advanced testing services to diagnose early HIV infection in gay me...
CBRC
 
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
Ad

Viewers also liked (19)

PDF
MyosMuscleHealth
Brian Ethridge
 
PPTX
Analysing movie posters.docx
lillymayb
 
DOCX
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
savanna501
 
DOCX
Skye Research project
Skye Lodge
 
DOC
Kenneth W Finney
Kenneth Finney
 
PPTX
Mi ple como me veo y me ven en la red.
victormanuellongoria
 
PDF
ROCK 4 PAWS ONE PAGE
Kassie Green
 
PDF
KMSU - June2015
Lamarr Sullivan
 
PDF
Articulo 2
atenitas12
 
DOCX
History test 4medio urbano rural y poblacion
cotepineiro
 
PDF
European ChemSex Forum Report
ReShape
 
PDF
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
Stuart Burns
 
PPTX
Radial vs Axial ventilation
sagnikroychowdhury
 
PPTX
ChemSex across Germany - What's known and what's not
ReShape
 
PPTX
The ChemSex phenomenon
ReShape
 
PPTX
Towards a ChemSex map: Overview of data and evidence
ReShape
 
PPTX
ChemSex and Injecting
ReShape
 
PPTX
Consent & Responsibility: a UK Perspective
ReShape
 
MyosMuscleHealth
Brian Ethridge
 
Analysing movie posters.docx
lillymayb
 
công ty dịch vụ giúp việc gia đình trọn gói ở hồ chí minh
savanna501
 
Skye Research project
Skye Lodge
 
Kenneth W Finney
Kenneth Finney
 
Mi ple como me veo y me ven en la red.
victormanuellongoria
 
ROCK 4 PAWS ONE PAGE
Kassie Green
 
KMSU - June2015
Lamarr Sullivan
 
Articulo 2
atenitas12
 
History test 4medio urbano rural y poblacion
cotepineiro
 
European ChemSex Forum Report
ReShape
 
TWCBC Dedicated Internet Access (DIA) Service Level Agreement_FINAL
Stuart Burns
 
Radial vs Axial ventilation
sagnikroychowdhury
 
ChemSex across Germany - What's known and what's not
ReShape
 
The ChemSex phenomenon
ReShape
 
Towards a ChemSex map: Overview of data and evidence
ReShape
 
ChemSex and Injecting
ReShape
 
Consent & Responsibility: a UK Perspective
ReShape
 
Ad

Similar to Bcn checkpoint - Michael Meulbroek (20)

PPTX
Chris Beyrer: "State of the Science: Key populations"
HopkinsCFAR
 
PPTX
Update on PDPH Strategic Plan – Sexual Health
Office of HIV Planning
 
PPTX
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
Office of HIV Planning
 
PPTX
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Office of HIV Planning
 
PDF
Current State of the HIV Epidemic Among MSM in Chicago
Chicago Department of Public Health
 
PDF
L A Mayor March 09 Calderon Leider
Jason Leider
 
PPTX
Worlds AIDS Day 2016 (Peurto Rican Cultural Center & Vida SIDA)
Tahseen Siddiqui
 
PDF
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
UC San Diego AntiViral Research Center
 
PDF
Top Ten HIV Clinical Controversies 2014
UC San Diego AntiViral Research Center
 
PPTX
Philadelphia Department of Public Health HIV Prevention Activities
Office of HIV Planning
 
PPTX
2014 Epidemiological Update by Dr. Kathleen Brady
Office of HIV Planning
 
PPT
Wesat2204
Mohamed Rafique
 
PPTX
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
PDF
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™
 
PDF
HHC Integration of HIV Testing Within Routine Care
Aquilino Gabor
 
PPTX
SCAETC BPHC_HIV Epi and Screening_Iandiorio.pptx
michellehardy89
 
PPTX
Special Needs for HIV+ Incarcerated Populations
Adam Thompson
 
PPTX
2.-Basics-of-HIV-and-STIs-2.powerpointpptx
LaurizeRhenBorja
 
PPT
Do 1 Thing - Dr. Stacey Trooskin
Office of HIV Planning
 
PPT
Do 1 Thing - Dr. Stacey Trooskin
Office of HIV Planning
 
Chris Beyrer: "State of the Science: Key populations"
HopkinsCFAR
 
Update on PDPH Strategic Plan – Sexual Health
Office of HIV Planning
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
Office of HIV Planning
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Office of HIV Planning
 
Current State of the HIV Epidemic Among MSM in Chicago
Chicago Department of Public Health
 
L A Mayor March 09 Calderon Leider
Jason Leider
 
Worlds AIDS Day 2016 (Peurto Rican Cultural Center & Vida SIDA)
Tahseen Siddiqui
 
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
UC San Diego AntiViral Research Center
 
Top Ten HIV Clinical Controversies 2014
UC San Diego AntiViral Research Center
 
Philadelphia Department of Public Health HIV Prevention Activities
Office of HIV Planning
 
2014 Epidemiological Update by Dr. Kathleen Brady
Office of HIV Planning
 
Wesat2204
Mohamed Rafique
 
Can we end the HIV/AIDS epidemic? Josip begovac
PinHealth
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™
 
HHC Integration of HIV Testing Within Routine Care
Aquilino Gabor
 
SCAETC BPHC_HIV Epi and Screening_Iandiorio.pptx
michellehardy89
 
Special Needs for HIV+ Incarcerated Populations
Adam Thompson
 
2.-Basics-of-HIV-and-STIs-2.powerpointpptx
LaurizeRhenBorja
 
Do 1 Thing - Dr. Stacey Trooskin
Office of HIV Planning
 
Do 1 Thing - Dr. Stacey Trooskin
Office of HIV Planning
 

More from ReShape (20)

PDF
European ChemSex forum report 2018
ReShape
 
PDF
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
PDF
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
PDF
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
PDF
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
PPTX
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
PPTX
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
ReShape
 
PPTX
The HIV Cascade - Dr Laura Waters
ReShape
 
PPTX
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
PPTX
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
PDF
G monitor sheet
ReShape
 
PDF
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
PDF
ChemSex
ReShape
 
PPT
ChemSex: a community policy response
ReShape
 
PPTX
ChemSex in therapy
ReShape
 
PPTX
ChemSex - Early Interventions Considerations
ReShape
 
PPTX
Siegfried Schwarze
ReShape
 
PDF
Psychosexual issues and ChemSex
ReShape
 
PPTX
PrEP and ChemSex: Looking forward
ReShape
 
PPTX
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 
European ChemSex forum report 2018
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 4
ReShape
 
Where's the hope? Dialogues for solidarity, Session 3
ReShape
 
Where's the Hope? Dialogues for Solidarity, Session 2
ReShape
 
Where's the hope? Dialogues for Solidarity - Session 1
ReShape
 
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
ReShape
 
The HIV Cascade - Dr Laura Waters
ReShape
 
New Treatment for hepatitis C: Impact on morbidity and mortality - Dr Helen H...
ReShape
 
Hepatitis C Generic Drugs - Stuart Flanagan
ReShape
 
G monitor sheet
ReShape
 
Outreach and community engagement. Supporting & resourcing the gay community ...
ReShape
 
ChemSex
ReShape
 
ChemSex: a community policy response
ReShape
 
ChemSex in therapy
ReShape
 
ChemSex - Early Interventions Considerations
ReShape
 
Siegfried Schwarze
ReShape
 
Psychosexual issues and ChemSex
ReShape
 
PrEP and ChemSex: Looking forward
ReShape
 
Club Drug Clinic, Project Neptune and the G Trial
ReShape
 

Recently uploaded (20)

PPTX
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 
PPTX
CVS INTRO.pptx therapeutics Cardiovascular disease
Dr. Sarita Sharma
 
PPT
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific An...
PVI, PeerView Institute for Medical Education
 
PPTX
Models for screening of Local Anaesthetics.pptx
AntoRajiv1
 
PDF
coagulation disorders in anaesthesia pdf
Assist. Prof. Radhwan Hazem Alkhashab
 
PDF
Noble Metals and Base Metals in Prosthodontics
Praveen Prabu
 
PPTX
12. Biomechanicsof the humanlowerextremity.pptx
Bolan University of Medical and Health Sciences ,Quetta
 
PPTX
1.2) Congestive Cardiac Failure.pptx Cardiovascular disease
Dr. Sarita Sharma
 
PPTX
INFLAMMATION
Soumyadip Datta
 
PPTX
13.Anesthesia and its all types.....pptx
Bolan University of Medical and Health Sciences ,Quetta
 
PPTX
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
PDF
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
Robertus Arian Datusanantyo
 
PPTX
Pharmacology is the scientific study of how drugs and other chemical substanc...
tarun35435605
 
PPTX
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
Shivankan Kakkar
 
PPTX
LOW GRADE GLIOMA MANAGEMENT BY DR KANHU CHARAN PATRO
Kanhu Charan
 
PDF
Consult Best Sexologist Patna Bihar Vascular ED Problems Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
PPTX
Omphalocele: PowerPoint presentation
Nathan Lupiya
 
PPTX
HALITOSIS presentation for Ear, Nose and throat.pptx
stefanumerah1
 
PPTX
Chemical Burn, Etiology, Types and Management.pptx
Dr. Junaid Khurshid
 
DOCX
Paediatrics Question Papers – III MBBS (Part II), RUHS Main Exam 2025-2016
Shivankan Kakkar
 
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 
CVS INTRO.pptx therapeutics Cardiovascular disease
Dr. Sarita Sharma
 
Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific An...
PVI, PeerView Institute for Medical Education
 
Models for screening of Local Anaesthetics.pptx
AntoRajiv1
 
coagulation disorders in anaesthesia pdf
Assist. Prof. Radhwan Hazem Alkhashab
 
Noble Metals and Base Metals in Prosthodontics
Praveen Prabu
 
12. Biomechanicsof the humanlowerextremity.pptx
Bolan University of Medical and Health Sciences ,Quetta
 
1.2) Congestive Cardiac Failure.pptx Cardiovascular disease
Dr. Sarita Sharma
 
INFLAMMATION
Soumyadip Datta
 
13.Anesthesia and its all types.....pptx
Bolan University of Medical and Health Sciences ,Quetta
 
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
Robertus Arian Datusanantyo
 
Pharmacology is the scientific study of how drugs and other chemical substanc...
tarun35435605
 
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
Shivankan Kakkar
 
LOW GRADE GLIOMA MANAGEMENT BY DR KANHU CHARAN PATRO
Kanhu Charan
 
Consult Best Sexologist Patna Bihar Vascular ED Problems Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Omphalocele: PowerPoint presentation
Nathan Lupiya
 
HALITOSIS presentation for Ear, Nose and throat.pptx
stefanumerah1
 
Chemical Burn, Etiology, Types and Management.pptx
Dr. Junaid Khurshid
 
Paediatrics Question Papers – III MBBS (Part II), RUHS Main Exam 2025-2016
Shivankan Kakkar
 

Bcn checkpoint - Michael Meulbroek

  • 1. bcn checkpoint V I H - S I D A ▪ I T S ▪ S E X U A L I T A T ▪ H O M E S ▪ S A L U T Results and Next Steps Michael Meulbroek Projecte dels NOMS-Hispanosida Challenges and opportunities for community testing centres Barcelona, 5 October de 2014
  • 3. Results 2007 2008 2009 2010 2011 2012 2013 1. Number of tests 1.065 1.228 2.485 3.425 3.837 5.051 5.062 2. Persons tested 903 1.124 2.201 2.896 3.198 4.049 4.030 3. HIV positive 37 72 113 126 132 138 138 4. % HIV positive 4,1% 6,4% 5,1% 4,4% 4,1% 3,4% 3,4% 5. Persons at first visit BCN Checkpoint 850 957 1.583 1.722 1.689 1.717 1.682 6. HIV positive at first visit 36 53 91 100 90 92 78 7. % HIV positive at first visit 4,2% 5,5% 5,7% 5,8% 5,3% 5,4% 4,6%
  • 4. Impact of BCN Checkpoint 2007 2008 2009 2010 2011 2012 2013 * (Prov.) 1. Number of tests 1.098 1.272 2.483 3.453 3.962 5.051 5.062 2. Persons tested 951 1.162 2.197 2.896 3.198 4.049 4.030 3. HIV positive 37 72 113 126 132 138 138 8. Total HIV cases in MSM reported in Catalonia 319 300 280 360 374 430 357 9. % of cases detected in BCN Checkpoint 11,6% 24,0% 40,4% 35,0% 35,3% 32,1% 38,7% * Data Ceeiscat 3rd October 2014
  • 5. Early detection • 31% of the new HIV cases detected in BCN Checkpoint are recent infections (< 6 months) • 57% of the new cases are infections < 12 months
  • 6. Linkage to HIV unit (2009-2013) 665 persons HIV reactive tests 633 persons HIV reactive tests 562 persons linked to care 14 previously HIV positive 71 persons non-linked 24 persons returned to country of origin 18 false positive 33 persons Excluded: self-linked to care 88,8% 14 persons lost 2,2% 3,8% 5,2%
  • 8. Results Check-ear (2009-2014) Prevalence higher than in the general population • 250 participants • 16% prevalence asymptomatic STIs at baseline (1/6) • Gonorrhea (rectum 5,6% / penis 2,0%) • Chlamydia (rectum 6,3% / penis 3,1%)
  • 9. Results Check-ear (2009-2014) Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected. Ruiz-Riol M, Llano A, Ibarrondo J, Zamarreño J, Yusim K, Bach V, Mothe B, Perez-Alvarez S, Fernandez MA, Requena G, Meulbroek M, Pujol F, Leon A, Cobarsi P, Korber BT, Clotet B, Ganoza C, Sanchez J, Coll J, Brander C. Journal Infectious Diseases 2014 Sep 23. pii: jiu534
  • 10. Next Steps Implementation of new services:  Syphilis, Chlamydia, Gonorrhea and HCV testing  Hepatitis A and B vaccination
  • 11. The ÍTACA Cohort (December 2008 – December 2013) 8.165 participants - 4.481 persons with follow-up visit 223 infections HIV Incidence HIV: 2,43 x 100 persons/year (95% CI: 2,13 – 2,77) General population: incidence = 0,02%
  • 12. Match prediction with reality? Prevalence and Awareness of HIV Infection Among Men Who Have Sex With Men — 21 Cities, United States, 2008 (MMWR, Sept. 24, 2010, 59(37) 1201-7) Ronald Stall, PhD. Best Practices in HIV Prevention: Translating Innovation into Action. Boston, September 27, 2013
  • 13. Next Steps So, we know what means an high HIV incidence… What are the behavior surveys we need? “HIV is increasing among MSM not because of greater risk-taking behavior, but simply because HIV is so prevalent among their sex partners that even one or two slip-ups can have devastating consequences.” Susan Buchbinder FDA Advisory Committee for PrEP approval 10th May 2012
  • 14. The effectiveness of condoms is limited / has peaked Uso del preservativo Siempre 714 56,3% Casi siempre 476 37,5% A veces 34 2,7% Casi nunca 15 1,2% Nunca 17 1,3% No contesta 13 1,0% Total 1,269 Estudio Ítaca - BCN Checkpoint (2008-2011) 93,8%
  • 15. What can reduce HIV incidence? A. Phillips. MSM in the UK: Prevention Effects of ART in Perspective. 21st CROI, Boston, abstract 116, 2014
  • 16. The problem: acute infections Source: Galvin/Cohen, 2004
  • 17. Next Steps: more regular testing
  • 18. Next Steps: use HIV RNA assay